Viewing data from:

MODAFINIL

ANDA

MODAFINIL | A209966 | CADILA HEALTHCARE LTD

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: PROVIGIL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 5 NDCs

Highest NADAC/Unit

$0.3483

per ea

Lowest NADAC/Unit

$0.2420

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
72578000601MODAFINIL 200 MG TABLET	$0.3483	EA	Generic	—	2026-08-19
72578000606MODAFINIL 200 MG TABLET	$0.3483	EA	Generic	—	2026-08-19
72578000616MODAFINIL 200 MG TABLET	$0.3483	EA	Generic	—	2026-08-19
72578000506MODAFINIL 100 MG TABLET	$0.2420	EA	Generic	—	2026-08-19
72578000516MODAFINIL 100 MG TABLET	$0.2420	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain10 active DMFs4 inactive

10 active API suppliers hold Drug Master Files for this ingredient.

CEPHALON INCMODAFINIL DRUG SUBSTANCE

DMF 119701996

WAVELENGTH ENTERPRISES LTDMODAFINIL

DMF 161402002

DIPHARMA FRANCIS SRLMODAFINIL USP

DMF 162502002

MATRIX PHARMACORP PRIVATE LTDMODAFINIL USP

DMF 163062002

TAPI NL BVMODAFINIL

DMF 163102002

ALEMBIC PHARMACEUTICALS LTDMODAFINIL USP

DMF 164772003

ORBION PHARMACEUTICALS PRIVATE LTDMODAFINIL

DMF 196452006

APITORIA PHARMA PRIVATE LTDMODAFINIL USP (NON-STERILE DRUG SUBSTANCE)

DMF 238982010

CHROMO LABORATORIES INDIA PRIVATE LTDMODAFINIL USP

DMF 369752022

SYMED LABS LTDMODAFINIL USP

DMF 385332023

UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)InactiveMODAFINIL

DMF 175452004

HAS HEALTHCARE ADVANCED SYNTHESIS SAInactiveMODAFINIL

DMF 178152004

FLAMMA SPAInactiveMODAFINIL

DMF 180622005

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveMODAFINIL

DMF 184112005

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 100MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Sep 14, 2017

No patent or exclusivity listings for this strength.

#002 — 200MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 14, 2017